Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Bateman

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Age and Ageing|July 1, 1989
Age and the pharmacokinetics of morphineS P Baillie, D N Bateman, P E Coates, et al.
Pharmacoeconomics|September 5, 1995
The pros and cons of generic medicinesM Campbell, D N Bateman, A Lee, et al.
BMJ (Clinical Research Ed.)|December 18, 2001
The impact of new drugs on management of glaucoma in Scotland: observational studyD N Bateman, R Clark, A Azuara-Blanco, et al.
Emergency Medicine Journal : EMJ|January 5, 2002
TOXBASE: poisons information on the internetD N Bateman, A M Good, W J Laing, et al.
Human & Experimental Toxicology|November 5, 2002
Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reportsJ J Oliver, C Kelly, D Jarvie, et al.
British Journal of Clinical Pharmacology|December 4, 2003
Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problemN J Langford, A M Good, W J Laing, et al.
Human & Experimental Toxicology|March 6, 2007
Poisons admissions in Edinburgh 1981-2001: agent trends and predictors of hospital readmissionsS B Rafnsson, J J Oliver, R A Elton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1979
Metoclopramide and haloperidol in tardive dyskinesiaD N Bateman, D K Dutta, H A McClelland, et al.
BMJ (Clinical Research Ed.)|August 30, 1997
Reporting of adverse drug reactions by hospital pharmacists: pilot schemeA Lee, D N Bateman, C Edwards, et al.
European Journal of Clinical Pharmacology|April 15, 2004
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?D N Bateman, J Chick, A M Good, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Age and Ageing|July 1, 1989
Age and the pharmacokinetics of morphineS P Baillie, D N Bateman, P E Coates, et al.
Pharmacoeconomics|September 5, 1995
The pros and cons of generic medicinesM Campbell, D N Bateman, A Lee, et al.
BMJ (Clinical Research Ed.)|December 18, 2001
The impact of new drugs on management of glaucoma in Scotland: observational studyD N Bateman, R Clark, A Azuara-Blanco, et al.
Emergency Medicine Journal : EMJ|January 5, 2002
TOXBASE: poisons information on the internetD N Bateman, A M Good, W J Laing, et al.
Human & Experimental Toxicology|November 5, 2002
Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reportsJ J Oliver, C Kelly, D Jarvie, et al.
British Journal of Clinical Pharmacology|December 4, 2003
Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problemN J Langford, A M Good, W J Laing, et al.
Human & Experimental Toxicology|March 6, 2007
Poisons admissions in Edinburgh 1981-2001: agent trends and predictors of hospital readmissionsS B Rafnsson, J J Oliver, R A Elton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1979
Metoclopramide and haloperidol in tardive dyskinesiaD N Bateman, D K Dutta, H A McClelland, et al.
BMJ (Clinical Research Ed.)|August 30, 1997
Reporting of adverse drug reactions by hospital pharmacists: pilot schemeA Lee, D N Bateman, C Edwards, et al.
European Journal of Clinical Pharmacology|April 15, 2004
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?D N Bateman, J Chick, A M Good, et al.
Pageof 19